Sign Up to like & get
recommendations!
0
Published in 2019 at "Nanotoxicology"
DOI: 10.1080/17435390.2019.1572809
Abstract: Abstract IONP (iron oxide nanoparticles) commercialized for treatments of iron anemia or cancer diseases can be administered at doses exceeding 1 g per patient, indicating their bio-compatibility when they are prepared in the right conditions. Various…
read more here.
Keywords:
biodistribution;
ionp;
iron anemia;
cancer ... See more keywords